Pathophysiological targets for non-pharmacological treatment of migraine

Cephalalgia

Volumn 36, Issue 12, 2016, Pages 1103-1111

  Coppola, Gianluca ^a   Di Lorenzo, Cherubino ^b   Serrao, Mariano ^c   Parisi, Vincenzo ^a   Schoenen, Jean ^d   Pierelli, Francesco ^c,e  

^a IRCCS FONDAZIONE BIETTI   (Italy)

^b IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY OF LIÈGE   (Belgium)

^e IRCCS NEUROMED   (Italy)

Author keywords

diets; migraine pathophysiology; neurostimulation; Non pharmacological treatment; nutraceuticals

Indexed keywords

MAGNESIUM ION; NUTRACEUTICAL; RIBOFLAVIN;

BRAIN LEVEL; CLINICAL EFFECTIVENESS; COGNITIVE BEHAVIORAL THERAPY; CRANIAL NERVE STIMULATION; CYTOKINE RELEASE; DIET THERAPY; HUMAN; INFLAMMATION; MIGRAINE; NERVE STIMULATION; NEUROFEEDBACK; NONHUMAN; OBESITY; OXIDATIVE PHOSPHORYLATION; PATHOPHYSIOLOGY; REVIEW; TRANSCRANIAL DIRECT CURRENT STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION; VAGUS NERVE STIMULATION; COGNITIVE THERAPY; DIETARY SUPPLEMENT; ELECTROTHERAPY; EVIDENCE BASED MEDICINE; MULTIMODALITY CANCER THERAPY; PROCEDURES; TREATMENT OUTCOME;

COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DIET THERAPY; DIETARY SUPPLEMENTS; ELECTRIC STIMULATION THERAPY; EVIDENCE-BASED MEDICINE; HUMANS; MIGRAINE DISORDERS; NEUROFEEDBACK; TREATMENT OUTCOME;

EID: 84992327063     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102415620908     Document Type: Review

References (81)

1. Orr S. Diet and nutraceutical interventions for headache management: A review of the evidence. Cephalalgia 2015; doi:10.1177/0333102415590239.
2. Ambrosini A, D'Alessio C, Magis D and Schoenen J. Targeting pericranial nerve branches to treat migraine: Current approaches and perspectives. Cephalalgia 2015; 35: 1308-1322.
3. Schoenen J, Magis D and Coppola G. Non-invasive neurostimulation methods for migraine therapy: The available evidence. Cephalalgia 2015; in press.
4. Wisse B,. The inflammatory syndrome: The role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol 2004; 15: 2792-2800.
5. Chae J, Paik J, Kang R, et al. Mild weight loss reduces inflammatory cytokines, leukocyte count, and oxidative stress in overweight and moderately obese participants treated for 3 years with dietary modification. Nutr Res 2013; 33: 195-203.
6. Tajik N, Keshavarz S, Masoudkabir F, et al. Effect of diet-induced weight loss on inflammatory cytokines in obese women. J Endocrinol Invest 2013; 36: 211-215.
7. Peterlin B, Bigal M, Tepper S, Urakaze M, Sheftell F, Rapoport A,. Migraine and adiponectin: Is there a connection? Cephalalgia 2007; 27: 435-446.
8. Gruber H, Bernecker C, Pailer S, et al. Hyperinsulinaemia in migraineurs is associated with nitric oxide stress. Cephalalgia 2010; 30: 593-598.
9. Bernecker C, Pailer S, Kieslinger P, et al. GLP-2 and leptin are associated with hyperinsulinemia in non-obese female migraineurs. Cephalalgia 2010; 30: 1366-1374.
10. Peterlin B, Alexander G, Tabby D, Reichenberger E,. Oligomerization state-dependent elevations of adiponectin in chronic daily headache. Neurology 2008; 70: 1905-1911.
11. Berilgen M, Bulut S, Gonen M, Tekatas A, Dag E, Mungen B,. Comparison of the effects of amitriptyline and flunarizine on weight gain and serum leptin, C peptide and insulin levels when used as migraine preventive treatment. Cephalalgia 2005; 25: 1048-1053.
12. Amer M, Woodward M, Appel L,. Effects of dietary sodium and the DASH diet on the occurrence of headaches: results from randomised multicentre DASH-Sodium clinical trial. BMJ Open 2014; 4: 10-10.
13. Alpay K, Ertas M, Orhan E, Ustay D, Lieners C, Baykan B,. Diet restriction in migraine, based on IgG against foods: a clinical double-blind, randomised, cross-over trial. Cephalalgia 2010; 30: 829-837.
14. Bunner A, Agarwal U, Gonzales J, Valente F, Barnard N,. Nutrition intervention for migraine: A randomized crossover trial. J Headache Pain 2014; 15: 69-69.
15. Di Lorenzo C, Currà A, Sirianni G, et al. Diet transiently improves migraine in two twin sisters: Possible role of ketogenesis? Funct Neurol 2013; 28: 305-308.
16. Di Lorenzo C, Coppola G, Sirianni G, et al. Migraine improvement during short lasting ketogenesis: A proof-of-concept study. Eur J Neurol 2015; 22: 170-177.
17. Wheless J,. History of the ketogenic diet. Epilepsia 2008; 8: 3-5.
18. Schnabel T,. An experience with a ketogenic dietary in migraine. Ann Intern Med 1928; 2: 341-347.
19. Cullingford T,. The ketogenic diet; fatty acids, fatty acid-activated receptors and neurological disorders. Prostaglandins Leukot Essent Fatty Acids 2004; 70: 253-264.
20. 31P magnetic resonance spectroscopy in patients affected by migraine with aura. Neurology 1992; 42: 1209-1214.
21. Montagna P, Cortelli P, Barbiroli B,. Magnetic resonance spectroscopy studies in migraine. Cephalalgia 1994; 14: 184-193.
22. Ojaimi J, Katsabanis S, Bower S, Quigley A, Byrne E,. Mitochondrial DNA in stroke and migraine with aura. Cerebrovasc Dis 1998; 8: 102-106.
23. Majamaa K, Finnilä S, Turkka J, Hassinen I,. Mitochondrial DNA haplogroup U as a risk factor for occipital stroke in migraine. Lancet 1998; 352: 455-456.
24. Zaki E, Freilinger T, Klopstock T, et al. Two common mitochondrial DNA polymorphisms are highly associated with migraine headache and cyclic vomiting syndrome. Cephalalgia 2009; 29: 719-728.
25. Guo S, Esserlind A, Andersson Z, et al. Prevalence of migraine in persons with the 3243A>G mutation in mitochondrial DNA. Eur J Neurol 2015; doi:10.1111/ene.12832.
26. Gerards M, van den Bosch BJ, Danhauser K, et al. Riboflavin-responsive oxidative phosphorylation complex I deficiency caused by defective ACAD9: New function for an old gene. Brain 2011; 134: 210-219.
27. Matthews R, Yang L, Browne S, Baik M, Beal M,. Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects. Proc Natl Acad Sci U S A. 1998; 95: 8892-8897.
28. 18F-DOPA uptake in genetically engineered mouse model of Parkinson's disease and the neuroprotective role of coenzyme Q10. Brain Res Bull 2006; 70: 22-32.
29. Rubin H,. The paradox of the contrasting roles of chronic magnesium deficiency in metabolic disorders and field cancerization. Magnes Res 2014; 27: 94-102.
30. Ramadan N, Halvorson H, Vande-Linde A, Levine S, Helpern J, Welch K,. Low brain magnesium in migraine. Headache 1989; 29: 416-419.
31. Boska M, Welch K, Barker P, Nelson J, Schultz L,. Contrasts in cortical magnesium, phospholipid and energy metabolism between migraine syndromes. Neurology 2002; 58: 1227-1233.
32. Schoenen J, Sianard-Gainko J, Lenaerts M,. Blood magnesium levels in migraine. Cephalalgia 1991; 11: 97-99.
33. Sarchielli P, Coata G, Firenze C, Morucci P, Abbritti G, Gallai V,. Serum and salivary magnesium levels in migraine and tension-type headache. Results in a group of adult patients. Cephalalgia 1992; 12: 21-27.
34. Coppola G, Schoenen J, Measures of cortical excitability. In: Borsook D, May A, Goadsby P, Hargreaves R, (eds). The Migraine Brain: Imaging Structure and Function, New York: Oxford University Press, 2012, pp. 321-338.
35. Coppola G, Di Lorenzo C, Schoenen J, Pierelli F,. Habituation and sensitization in primary headaches. J Headache Pain 2013; 14: 65-65.
36. Bohotin V, Fumal A, Vandenheede M, et al. Effects of repetitive transcranial magnetic stimulation on visual evoked potentials in migraine. Brain 2002; 125: 912-922.
37. Coppola G, De Pasqua V, Pierelli F, Schoenen J,. Effects of repetitive transcranial magnetic stimulation on somatosensory evoked potentials and high frequency oscillations in migraine. Cephalalgia 2012; 32: 700-709.
38. Coppola G, Vandenheede M, Di Clemente L, et al. Somatosensory evoked high-frequency oscillations reflecting thalamo-cortical activity are decreased in migraine patients between attacks. Brain 2005; 128: 98-103.
39. Polanía R, Paulus W, Nitsche M,. Modulating cortico-striatal and thalamo-cortical functional connectivity with transcranial direct current stimulation. Hum Brain Mapp 2012; 33: 2499-2508.
40. Fumal A, Coppola G, Bohotin V, et al. Induction of long-lasting changes of visual cortex excitability by five daily sessions of repetitive transcranial magnetic stimulation (rTMS) in healthy volunteers and migraine patients. Cephalalgia 2006; 26: 143-149.
41. Viganò A, D'Elia T, Sava S, et al. Transcranial direct current stimulation (tDCS) of the visual cortex: A proof-of-concept study based on interictal electrophysiological abnormalities in migraine. J Headache Pain 2013; 14: 23-23.
42. Chadaide Z, Arlt S, Antal A, Nitsche M, Lang N, Paulus W,. Transcranial direct current stimulation reveals inhibitory deficiency in migraine. Cephalalgia 2007; 27: 833-839.
43. Holland P, Schembri C, Fredrick J, Goadsby P,. Transcranial magnetic stimulation for the treatment of migraine aura? Cephalalgia 2009; 29: PO29-PO29.
44. Khodaie B, Saba V, Ahmadi M, Lotfinia A, Lotfinia M,. Effect of transcranial magnetic stimulation on cellular anatomy after repetitive cortical spreading depression. Cephalalgia 2015; 35: PO037-PO037.
45. Liebetanz D, Fregni F, Monte-Silva K, et al. After-effects of transcranial direct current stimulation (tDCS) on cortical spreading depression. Neurosci Lett 2006; 398: 85-90.
46. Fregni F, Liebetanz D, Monte-Silva K, et al. Effects of transcranial direct current stimulation coupled with repetitive electrical stimulation on cortical spreading depression. Exp Neurol 2007; 204: 462-466.
47. Kerr F,. Central relationships of trigeminal and cervical primary afferents in the spinal cord and medulla. Brain Res 1972; 43: 561-572.
48. Stankewitz A, Aderjan D, Eippert F, May A,. Trigeminal nociceptive transmission in migraineurs predicts migraine attacks. J Neurosci 2011; 31: 1937-1943.
49. Katsarava Z, Giffin N, Diener HC, Kaube H,. Abnormal habituation of 'nociceptive' blink reflex in migraine-evidence for increased excitability of trigeminal nociception. Cephalalgia 2003; 23: 814-819.
50. Di Clemente L, Coppola G, Magis D, Fumal A, De Pasqua V, Schoenen J,. Nociceptive blink reflex and visual evoked potential habituations are correlated in migraine. Headache 2005; 45: 1388-1393.
51. Di Clemente L, Coppola G, Magis D, et al. Interictal habituation deficit of the nociceptive blink reflex: An endophenotypic marker for presymptomatic migraine? Brain 2007; 130: 765-770.
52. Coppola G, Di Clemente L, Fumal A, et al. Inhibition of the nociceptive R2 blink reflex after supraorbital or index finger stimulation is normal in migraine without aura between attacks. Cephalalgia 2007; 27: 803-808.
53. de Tommaso M, Guido M, Libro G, et al. Abnormal brain processing of cutaneous pain in migraine patients during the attack. Neurosci Lett 2002; 333: 29-32.
54. Kaube H, Katsarava Z, Przywara S, Drepper J, Ellrich J, Diener HC,. Acute migraine headache: Possible sensitization of neurons in the spinal trigeminal nucleus? Neurology 2002; 58: 1234-1238.
55. Villanueva L, Noseda R, Trigeminal mechanisms of nociception. In: McMahon SB, Koltzenburg M, Tracey I, Turk DC, (eds). Wall and Melzack's Textbook of Pain, Philadelphia: Elsevier Health Sciences, 2013, pp. 793-802.
56. Matharu MS, Bartsch T, Ward N, Frackowiak RSJ, Weiner R, Goadsby PJ,. Central neuromodulation in chronic migraine patients with suboccipital stimulators: A PET study. Brain 2004; 127: 220-230.
57. Magis D, Bruno M, Fumal A, et al. Central modulation in cluster headache patients treated with occipital nerve stimulation: An FDG-PET study. BMC Neurol 2011; 11: 25-25.
58. Chandler M, Zhang J, Foreman R,. Vagal, sympathetic and somatic sensory inputs to upper cervical (C1-C3) spinothalamic tract neurons in monkeys. J Neurophysiol 1996; 76: 2555-2567.
59. Narayanan J, Watts R, Haddad N, Labar D, Li P, Filippi C,. Cerebral activation during vagus nerve stimulation: a functional MR study. Epilepsia 2002; 43: 1509-1514.
60. Fornai F, Ruffoli R, Giorgi F, Paparelli A,. The role of locus coeruleus in the antiepileptic activity induced by vagus nerve stimulation. Eur J Neurosci 2011; 33: 2169-2178.
61. Fernández-Guardiola A, Martínez A, Valdés-Cruz A, Magdaleno-Madrigal V, Martínez D, Fernández-Mas R,. Vagus nerve prolonged stimulation in cats: Effects on epileptogenesis (amygdala electrical kindling): Behavioral and electrographic changes. Epilepsia 1999; 40: 822-829.
62. Martínez-Vargas D, Valdés-Cruz A, Magdaleno-Madrigal V, Almazán-Alvarado S, Fernández-Mas R,. Effects of electrical stimulation of the vagus nerve on the development of visual habituation in the cat. Behav Brain Res 2009; 205: 45-49.
63. Randich A, Gebhart G,. Vagal afferent modulation of nociception. Brain Res Brain Res Rev 1992; 17: 77-99.
64. Kirchner A, Birklein F, Stefan H, Handwerker H,. Left vagus nerve stimulation suppresses experimentally induced pain. Neurology 2000; 55: 1167-1171.
65. Lyubashina O, Sokolov A, Panteleev S,. Vagal afferent modulation of spinal trigeminal neuronal responses to dural electrical stimulation in rats. Neuroscience 2012; 222: 29-37.
66. Sadler R, Purdy R, Rahey S,. Vagal nerve stimulation aborts migraine in patient with intractable epilepsy. Cephalalgia 2002; 22: 482-484.
67. Hord E, Evans M, Mueed S, Adamolekun B, Naritoku D,. The effect of vagus nerve stimulation on migraines. J Pain 2003; 4: 530-534.
68. Lenaerts M, Oommen K, Couch J, Skaggs V,. Can vagus nerve stimulation help migraine? Cephalalgia 2008; 28: 392-395.
69. Basic S, Sporis D, Chudy D, Grahovac G, Nevajda B,. The effect of vagus nerve stimulation on migraine in patient with intractable epilepsy: Case report. Neurol Sci 2013; 34: 797-798.
70. Mauskop A,. Vagus nerve stimulation relieves chronic refractory migraine and cluster headaches. Cephalalgia 2005; 25: 82-86.
71. Cecchini AP, Mea E, Tullo V, et al. Vagus nerve stimulation in drug-resistant daily chronic migraine with depression: preliminary data. Neurol Sci 2009; 1: S101-S104.
72. Russo A, Tessitore A, Giordano A, et al. Executive resting-state network connectivity in migraine without aura. Cephalalgia 2012; 32: 1041-1048.
73. Schwedt T, Schlaggar B, Mar S, et al. Atypical resting-state functional connectivity of affective pain regions in chronic migraine. Headache 2013; 53: 737-751.
74. Coppola G, Di Renzo A, Tinelli E, et al. Evidence for brain morphometric changes during the migraine cycle: A magnetic resonance-based morphometry study. Cephalalgia 2015; 35: 783-791.
75. Holroyd K, Cottrell C, O'Donnell F, et al. Effect of preventive (beta blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine: Randomised controlled trial. BMJ 2010; 341: 10-10.
76. Ninaus M, Kober S, Witte M, Koschutnig K, Neuper C, Wood G,. Brain volumetry and self-regulation of brain activity relevant for neurofeedback. Biol Psychol 2015; 110: 126-133.
77. Gruzelier J,. EEG-neurofeedback for optimising performance. I: A review of cognitive and affective outcome in healthy participants. Neurosci Biobehav Rev 2014; 44: 124-141.
78. Birbaumer N, Ruiz S, Sitaram R,. Learned regulation of brain metabolism. Trends Cogn Sci 2013; 17: 295-302.
79. Sulzer J, Sitaram R, Blefari M, et al. Neurofeedback-mediated self-regulation of the dopaminergic midbrain. Neuroimage 2013; 83: 817-825.
80. Ros T, Théberge J, Frewen P, et al. Mind over chatter: Plastic up-regulation of the fMRI salience network directly after EEG neurofeedback. Neuroimage 2013; 65: 324-335.
81. Haller S, Kopel R, Jhooti P, et al. Dynamic reconfiguration of human brain functional networks through neurofeedback. Neuroimage 2013; 81: 243-252.